What are the key factors driving the growth of market?

Technological advancements in testing methods as well as in analyzer instruments and evolving regulations for in-vitro diagnostics are the key factors driving the growth of market

Market Research Services and Market Research

In Vitro Diagnostics (IVD) Market

MMC001256
Category: Healthcare & Life Sciences
Nov.2024
Publisher id : Meridian Market Consultants
No. of pages : 239
Rating :
Format : PDF,PPT

Report Description
Table Of Content

In Vitro Diagnostics Market Overview

The report is titled as ‘In Vitro Diagnostics Market: Opportunity Analysis and Future Assessment 2020-2028’. An overview of conceptual frameworks, analytical approaches of the In Vitro Diagnostics market is the main objective of the report, which further consists the market opportunity and insights of the data involved in the making of the respective market. In Vitro Diagnostics market is expected to grow with significant rate in the near future.

The global In Vitro Diagnostics (IVD) market in 2020 is estimated for more than US$ 70,561.9 Mn and expected to reach a value of US$ 1,03,310.9 Mn by 2028 with a significant CAGR of 4.9%.

In Vitro Diagnostics Market Dynamics

In-vitro diagnostics are tests performed in laboratories on biological samples such as blood, urine, tissue, etc. In vitro diagnostic are not only used for diagnosis but also provides useful information on monitoring of disease and treatment. Two-thirds of today’s clinical diagnoses involve in vitro diagnostics, hence are referred to as the backbone of healthcare.

In-vitro diagnostics market has witnessed substantial growth in last decade owing to technological advancements in testing methods as well as in analyzer instruments. According to the EPRS report, there are over 40,000 different IVD products available in the European market and per capita annual spending on IVD is approximately US$ 26. In-vitro diagnostics help to reduce the healthcare cost by making treatments more efficient and precise.

Evolving regulations for in-vitro diagnostics is the major driving force for market growth over the forecast period. For instance, regulation of medical devices in the European Union (EU) is undergoing a significant transformation with expanding the scope for in vitro diagnostics, which is expected to impact the increased product approvals for IVD in the region. Significant progress in point-of-care testing is another factor driving the growth of the global in-vitro diagnostics market. Introduction of molecular based assays and identification of range of biomarkers has opened up huge new opportunity for growth of global in-vitro diagnostics market.

In Vitro Diagnostics Market Competitive Landscape

Global market for in vitro diagnostics is dominated by Abbott Laboratories, Merck KGaG, F. Hoffman-La Roche AG, Becton Dickinson & Company, Danaher Corporation, Thermo Fisher Scientific Inc., Qiagen N.V., Diasorin S.P.A., biomerieux SA, Alere Inc., Bayer AG, Bio-Rad Laboratories Inc., Sysmex Corporation, etc. to name a few.

In Vitro Diagnostics Market Segmentation

The global in vitro diagnostics market is segmented on the basis of product type, technology, end user and region. On the basis of product type, in vitro diagnostics market is segmented as reagents and kits, analyze, and consumables. Based on technology, global market is segmented as immunochemistry, molecular diagnostics, hematology, point-of-care diagnostics, tissue diagnostics and clinical chemistry. On the basis of end user, global in vitro diagnostics market is segmented into hospitals, diagnostic centers, clinics, home care settings and others.

By Products & Services

• Reagents & Kits

• Instruments

o Fully Automated Instruments

o Semi-Automated Instruments

o Other Instruments

• Data Management Software

• Services

By Technology

• Immunoassay/Immunochemistry

o Enzyme-Linked Immunosorbent Assay

 Chemiluminescence Immunoassays

 Fluorescence Immunoassays

 Colorimetric Immunoassays

o Radioimmunoassay

o Rapid Test

o Western Blotting

o Enzyme-Linked Immunospot Assays

• Clinical Chemistry

o Basic Metabolic Panel

o Electrolyte Panel

o Liver Panel

o Lipid Profile

o Renal Profile

o Thyroid Function Panel

o Specialty Chemical Tests

o Molecular Diagnostics

o Polymerase Chain Reaction

o Isothermal Nucleic Acid Amplification Technology

o Microarray

o Hybridization

o DNA Sequencing & Next-Generation Sequencing

o Other Mdx Technologies

• Microbiology

• Hematology

• Coagulation and Hemostasis

• Urinalysis

• Other IVD Technologies

By Application

• Infectious Diseases

• Diabetes

• Oncology

• Cardiology

• Autoimmune Diseases

• Nephrology

• Drug Testing/Pharmacogenomics

• HIV/Aids

• Other Applications

By End User

• Hospitals

• Laboratories

o Large/Reference Laboratories

o Medium-Sized Laboratories

o Small Laboratories

• Point-Of-Care Testing

• Patient Self-Testing

• Academic Institutes

• Other End Users

By Region

• North America

• Latin America

• Europe

• Asia Pacific

• Middle East

• Africa

In Vitro Diagnostics Market Regional Segmentation

On the basis of region, the global in vitro diagnostics market is segmented into six regions namely North America, Latin America, Asia Pacific, Europe, Middle East, and Africa. North America in vitro diagnostics market is expected to be the most dominating market throughout the forecast period due to growing number of product approvals. Presence of key players in Europe makes it second largest market for in vitro diagnostics.

Asia Pacific in vitro diagnostics market is expected to witness highest growth rate due to increasing number local players in China and India. In terms revenue in 2018, North America is accounted to hold more than 40% of the market share, owing to favorable government regulations and presence of the key players in the region, also advancement in technology and advanced healthcare infrastructure also lead to the growth of In vitro diagnostic market in this region.

MMC Overview on In Vitro Diagnostics Market Report

The non-identical approach of Meridian Market Consultants stands with conceptual methods backed up with the data analysis. The novel market understanding approach makes up the standard of the assessment results that give better opportunity for the customers to put their effort.

A research report on the In Vitro Diagnostics market by Meridian Market Consultants is an in-depth and extensive study of the market based on the necessary data crunching and statistical analysis. It provides a brief view of the dynamics flowing through the market, which includes the factors that supports market and the factors that are acting as impedance for the growth of the market.

Furthermore, the report includes the various trends and opportunities in the respective market in different regions for a better understanding of readers that helps to analyze the potential of the market.

Factors that are benchmarked while estimating the market

Various factors that are benchmarked while estimating the market growth includes (but not restricted to):

New product designs and launches

Current product compliance

Reimbursement

Concerns for use of In Vitro Diagnostics

Advantages of In Vitro Diagnostics

Actions taken by the manufacturer and respective regulatory authorities also impact the market growth of the segment. These factors are understood at regional level and in major countries globally for providing regional insights of the product segment in the report. This helps our clients to take informed decision.

A mix of top-down and bottom-up approach is followed to arrive and validate our market value estimations. For a product segment like wherein one/two manufacturer(s) dominates the market, it’s products sales, previous growth rates and market expansion plans are considered to generate market share in the global market.

1. Global In Vitro Diagnostic Market Report Overview

1.1. Introduction

1.2. Report Description

1.3. Methodology

2. Global In Vitro Diagnostic Market Overview

2.1. Introduction

2.1.1. Market Definition

2.1.2. Market Taxonomy

2.2. Executive Summary

2.3. Global In Vitro Diagnostic Market Snapshot

2.4. Global In Vitro Diagnostic Market Size and Forecast, 2019–2027

2.4.1. Introduction

2.4.2. Market Value Forecast and Annual Growth Rate (AGR) Comparison (2019–2027)

2.5. Global In Vitro Diagnostic Market Dynamics

2.5.1. Drivers

2.5.2. Restraints

2.5.3. Opportunity

2.5.4. Trends

2.6. Key Regulations

2.7. Porter’s Five Forces Model

3. Global In Vitro Diagnostic Market, By Product & Services

3.1. Introduction

3.1.1. Annual Growth Rate Comparison, By Product & Services

3.1.2. BPS Analysis, By Product & Services

3.2. Market Revenue (US$Mn) Forecast, By Product & Services

3.2.1. Reagents & Kits

3.2.2. Instruments

3.2.2.1. Fully Automated Instruments

3.2.2.2. Semi-Automated Instruments

3.2.2.3. Other Instruments

3.2.3. Data Management Software

3.2.4. Services

3.3. Global In Vitro Diagnostic Market Attractiveness Index, By Product & Services

4. Global In Vitro Diagnostic Market, By Technology

4.1. Introduction

4.1.1. Annual Growth Rate Comparison, By Technology

4.1.2. BPS Analysis, By Technology

4.2. Market Revenue (US$Mn) Forecast, By Technology

4.2.1. Immunoassay/Immunochemistry

4.2.1.1. Enzyme-Linked Immunosorbent Assay

4.2.1.1.1. Chemiluminescence Immunoassays

4.2.1.1.2. Fluorescence Immunoassays

4.2.1.1.3. Colorimetric Immunoassays

4.2.1.2. Radioimmunoassay

4.2.1.3. Rapid Test

4.2.1.4. Western Blotting

4.2.1.5. Enzyme-Linked Immunospot Assays

4.2.2. Clinical Chemistry

4.2.2.1. Basic Metabolic Panel

4.2.2.2. Electrolyte Panel

4.2.2.3. Liver Panel

4.2.2.4. Lipid Profile

4.2.2.5. Renal Profile

4.2.2.6. Thyroid Function Panel

4.2.2.7. Specialty Chemical Tests

4.2.2.8. Molecular Diagnostics

4.2.2.9. Polymerase Chain Reaction

4.2.2.10. Isothermal Nucleic Acid Amplification Technology

4.2.2.11. Microarray

4.2.2.12. Hybridization

4.2.2.13. DNA Sequencing & Next-Generation Sequencing

4.2.2.14. Other Mdx Technologies

4.2.3. Microbiology

4.2.4. Hematology

4.2.5. Coagulation and Haemostasis

4.2.6. Urinalysis

4.2.7. Other IVD Technologies

4.3. Global In Vitro Diagnostic Market Attractiveness Index, By Technology

5. Global In Vitro Diagnostic Market, By Application

5.1. Introduction

5.1.1. Annual Growth Rate Comparison, By Application

5.1.2. BPS Analysis, By Application

5.2. Market Revenue (US$Mn) Forecast, By Application

5.2.1. Infectious Diseases

5.2.2. Diabetes

5.2.3. Oncology

5.2.4. Cardiology

5.2.5. Autoimmune Diseases

5.2.6. Nephrology

5.2.7. Drug Testing/Pharmacogenomics

5.2.8. HIV/Aids

5.2.9. Other Applications

5.3. Global In Vitro Diagnostic Market Attractiveness Index, By Application

6. Global In Vitro Diagnostic Market, By End User

6.1. Introduction

6.1.1. Annual Growth Rate Comparison, By End User

6.1.2. BPS Analysis, By End User

6.2. Market Revenue (US$Mn) Forecast, By End User

6.2.1. Hospitals

6.2.2. Laboratories

6.2.2.1. Large/Reference Laboratories

6.2.2.2. Medium-Sized Laboratories

6.2.2.3. Small Laboratories

6.2.3. Point-Of-Care Testing

6.2.4. Patient Self-Testing

6.2.5. Academic Institutes

6.2.6. Other End Users

6.3. Global In Vitro Diagnostic Market Attractiveness Index, By End User

7. Global In Vitro Diagnostic Market, By Region

7.1. Introduction

7.1.1. Annual Growth Rate Comparison, By Region

7.1.2. BPS Analysis, By Region

7.2. Market Revenue (US$Mn) Forecast, By Region

7.2.1. North America

7.2.2. Latin America

7.2.3. Europe

7.2.4. Asia Pacific

7.2.5. Middle East

7.2.6. Africa

7.3. Global In Vitro Diagnostic Market Attractiveness Index, By Region

8. North America In Vitro Diagnostic Market Analysis and Forecast, 2019–2027

8.1. Introduction

8.1.1. Annual Growth Rate Comparison, By Country

8.1.2. BPS Analysis, By Country

8.2. Market Revenue (US$Mn) Forecast, By Country

8.2.1. U.S. In Vitro Diagnostic Market

8.2.2. Canada In Vitro Diagnostic Market

8.3. North America In Vitro Diagnostic Market, By Product & Services

8.3.1. Reagents & Kits

8.3.2. Instruments

8.3.2.1. Fully Automated Instruments

8.3.2.2. Semi-Automated Instruments

8.3.2.3. Other Instruments

8.3.3. Data Management Software

8.3.4. Services

8.4. North America In Vitro Diagnostic Market, By Technology

8.4.1. Immunoassay/Immunochemistry

8.4.1.1. Enzyme-Linked Immunosorbent Assay

8.4.1.1.1. Chemiluminescence Immunoassays

8.4.1.1.2. Fluorescence Immunoassays

8.4.1.1.3. Colorimetric Immunoassays

8.4.1.2. Radioimmunoassay

8.4.1.3. Rapid Test

8.4.1.4. Western Blotting

8.4.1.5. Enzyme-Linked Immunospot Assays

8.4.2. Clinical Chemistry

8.4.2.1. Basic Metabolic Panel

8.4.2.2. Electrolyte Panel

8.4.2.3. Liver Panel

8.4.2.4. Lipid Profile

8.4.2.5. Renal Profile

8.4.2.6. Thyroid Function Panel

8.4.2.7. Specialty Chemical Tests

8.4.2.8. Molecular Diagnostics

8.4.2.9. Polymerase Chain Reaction

8.4.2.10. Isothermal Nucleic Acid Amplification Technology

8.4.2.11. Microarray

8.4.2.12. Hybridization

8.4.2.13. DNA Sequencing & Next-Generation Sequencing

8.4.2.14. Other Mdx Technologies

8.4.3. Microbiology

8.4.4. Hematology

8.4.5. Coagulation and Haemostasis

8.4.6. Urinalysis

8.4.7. Other IVD Technologies

8.5. North America In Vitro Diagnostic Market, By Application

8.5.1. Infectious Diseases

8.5.2. Diabetes

8.5.3. Oncology

8.5.4. Cardiology

8.5.5. Autoimmune Diseases

8.5.6. Nephrology

8.5.7. Drug Testing/Pharmacogenomics

8.5.8. HIV/Aids

8.5.9. Other Applications

8.6. North America In Vitro Diagnostic Market, By End User

8.6.1. Hospitals

8.6.2. Laboratories

8.6.2.1. Large/Reference Laboratories

8.6.2.2. Medium-Sized Laboratories

8.6.2.3. Small Laboratories

8.6.3. Point-Of-Care Testing

8.6.4. Patient Self-Testing

8.6.5. Academic Institutes

8.6.6. Other End Users

8.7. North America In Vitro Diagnostic Market Attractiveness Index

8.7.1. By Country

8.7.2. By Product & Services

8.7.3. By Technology

8.7.4. By Application

8.7.5. By End User

9. Latin America In Vitro Diagnostic Market Analysis and Forecast, 2019–2027

9.1. Introduction

9.1.1. Annual Growth Rate Comparison, By Country

9.1.2. BPS Analysis, By Country

9.2. Market (US$Mn) Forecast, By Country

9.2.1. Brazil In Vitro Diagnostic Market

9.2.2. Mexico In Vitro Diagnostic Market

9.2.3. Argentina In Vitro Diagnostic Market

9.2.4. Rest of Latin America In Vitro Diagnostic Market

9.3. Latin America In Vitro Diagnostic Market, By Product & Services

9.3.1. Reagents & Kits

9.3.2. Instruments

9.3.2.1. Fully Automated Instruments

9.3.2.2. Semi-Automated Instruments

9.3.2.3. Other Instruments

9.3.3. Data Management Software

9.3.4. Services

9.4. Latin America In Vitro Diagnostic Market, By Technology

9.4.1. Immunoassay/Immunochemistry

9.4.1.1. Enzyme-Linked Immunosorbent Assay

9.4.1.1.1. Chemiluminescence Immunoassays

9.4.1.1.2. Fluorescence Immunoassays

9.4.1.1.3. Colorimetric Immunoassays

9.4.1.2. Radioimmunoassay

9.4.1.3. Rapid Test

9.4.1.4. Western Blotting

9.4.1.5. Enzyme-Linked Immunospot Assays

9.4.2. Clinical Chemistry

9.4.2.1. Basic Metabolic Panel

9.4.2.2. Electrolyte Panel

9.4.2.3. Liver Panel

9.4.2.4. Lipid Profile

9.4.2.5. Renal Profile

9.4.2.6. Thyroid Function Panel

9.4.2.7. Specialty Chemical Tests

9.4.2.8. Molecular Diagnostics

9.4.2.9. Polymerase Chain Reaction

9.4.2.10. Isothermal Nucleic Acid Amplification Technology

9.4.2.11. Microarray

9.4.2.12. Hybridization

9.4.2.13. DNA Sequencing & Next-Generation Sequencing

9.4.2.14. Other Mdx Technologies

9.4.3. Microbiology

9.4.4. Hematology

9.4.5. Coagulation and Haemostasis

9.4.6. Urinalysis

9.4.7. Other IVD Technologies

9.5. Latin America In Vitro Diagnostic Market, By Application

9.5.1. Infectious Diseases

9.5.2. Diabetes

9.5.3. Oncology

9.5.4. Cardiology

9.5.5. Autoimmune Diseases

9.5.6. Nephrology

9.5.7. Drug Testing/Pharmacogenomics

9.5.8. HIV/Aids

9.5.9. Other Applications

9.6. Latin America In Vitro Diagnostic Market, By End User

9.6.1. Hospitals

9.6.2. Laboratories

9.6.2.1. Large/Reference Laboratories

9.6.2.2. Medium-Sized Laboratories

9.6.2.3. Small Laboratories

9.6.3. Point-Of-Care Testing

9.6.4. Patient Self-Testing

9.6.5. Academic Institutes

9.6.6. Other End Users

9.7. Latin America In Vitro Diagnostic Market Attractiveness Index

9.7.1. By Country

9.7.2. By Product & Services

9.7.3. By Technology

9.7.4. By Application

9.7.5. By End User

10. Europe In Vitro Diagnostic Market Analysis and Forecast, 2019–2027

10.1. Introduction

10.1.1. Annual Growth Rate Comparison, By Country

10.1.2. BPS Analysis, By Country

10.2. Market (US$Mn) Forecast, By Country

10.2.1. U.K. In Vitro Diagnostic Market

10.2.2. Germany In Vitro Diagnostic Market

10.2.3. Italy In Vitro Diagnostic Market

10.2.4. France In Vitro Diagnostic Market

10.2.5. Spain In Vitro Diagnostic Market

10.2.6. Russia In Vitro Diagnostic Market

10.2.7. Poland In Vitro Diagnostic Market

10.2.8. BENELUX In Vitro Diagnostic Market

10.2.9. NORDIC In Vitro Diagnostic Market

10.2.10. Rest of Europe In Vitro Diagnostic Market

10.3. Europe In Vitro Diagnostic Market, By Product & Services

10.3.1. Reagents & Kits

10.3.2. Instruments

10.3.2.1. Fully Automated Instruments

10.3.2.2. Semi-Automated Instruments

10.3.2.3. Other Instruments

10.3.3. Data Management Software

10.3.4. Services

10.4. Europe In Vitro Diagnostic Market, By Technology

10.4.1. Immunoassay/Immunochemistry

10.4.1.1. Enzyme-Linked Immunosorbent Assay

10.4.1.1.1. Chemiluminescence Immunoassays

10.4.1.1.2. Fluorescence Immunoassays

10.4.1.1.3. Colorimetric Immunoassays

10.4.1.2. Radioimmunoassay

10.4.1.3. Rapid Test

10.4.1.4. Western Blotting

10.4.1.5. Enzyme-Linked Immunospot Assays

10.4.2. Clinical Chemistry

10.4.2.1. Basic Metabolic Panel

10.4.2.2. Electrolyte Panel

10.4.2.3. Liver Panel

10.4.2.4. Lipid Profile

10.4.2.5. Renal Profile

10.4.2.6. Thyroid Function Panel

10.4.2.7. Specialty Chemical Tests

10.4.2.8. Molecular Diagnostics

10.4.2.9. Polymerase Chain Reaction

10.4.2.10. Isothermal Nucleic Acid Amplification Technology

10.4.2.11. Microarray

10.4.2.12. Hybridization

10.4.2.13. DNA Sequencing & Next-Generation Sequencing

10.4.2.14. Other Mdx Technologies

10.4.3. Microbiology

10.4.4. Hematology

10.4.5. Coagulation and Haemostasis

10.4.6. Urinalysis

10.4.7. Other IVD Technologies

10.5. Europe In Vitro Diagnostic Market, By Application

10.5.1. Infectious Diseases

10.5.2. Diabetes

10.5.3. Oncology

10.5.4. Cardiology

10.5.5. Autoimmune Diseases

10.5.6. Nephrology

10.5.7. Drug Testing/Pharmacogenomics

10.5.8. HIV/Aids

10.5.9. Other Applications

10.6. Europe In Vitro Diagnostic Market, By End User

10.6.1. Hospitals

10.6.2. Laboratories

10.6.2.1. Large/Reference Laboratories

10.6.2.2. Medium-Sized Laboratories

10.6.2.3. Small Laboratories

10.6.3. Point-Of-Care Testing

10.6.4. Patient Self-Testing

10.6.5. Academic Institutes

10.6.6. Other End Users

10.7. Europe In Vitro Diagnostic Market Attractiveness Index

10.7.1. By Country

10.7.2. By Product & Services

10.7.3. By Technology

10.7.4. By Application

10.7.5. By End User

11. Asia Pacific In Vitro Diagnostic Market Analysis and Forecast, 2019–2027

11.1. Introduction

11.1.1. Annual Growth Rate Comparison, By Country

11.1.2. BPS Analysis, By Country

11.2. Market (US$Mn) Forecast, By Country

11.2.1. China In Vitro Diagnostic Market

11.2.2. India In Vitro Diagnostic Market

11.2.3. Japan In Vitro Diagnostic Market

11.2.4. Australia and New Zealand In Vitro Diagnostic Market

11.2.5. South Korea In Vitro Diagnostic Market

11.2.6. ASEAN In Vitro Diagnostic Market

11.2.7. Rest of Asia Pacific In Vitro Diagnostic Market

11.3. Asia Pacific In Vitro Diagnostic Market, By Product & Services

11.3.1. Reagents & Kits

11.3.2. Instruments

11.3.2.1. Fully Automated Instruments

11.3.2.2. Semi-Automated Instruments

11.3.2.3. Other Instruments

11.3.3. Data Management Software

11.3.4. Services

11.4. Asia Pacific In Vitro Diagnostic Market, By Technology

11.4.1. Immunoassay/Immunochemistry

11.4.1.1. Enzyme-Linked Immunosorbent Assay

11.4.1.1.1. Chemiluminescence Immunoassays

11.4.1.1.2. Fluorescence Immunoassays

11.4.1.1.3. Colorimetric Immunoassays

11.4.1.2. Radioimmunoassay

11.4.1.3. Rapid Test

11.4.1.4. Western Blotting

11.4.1.5. Enzyme-Linked Immunospot Assays

11.4.2. Clinical Chemistry

11.4.2.1. Basic Metabolic Panel

11.4.2.2. Electrolyte Panel

11.4.2.3. Liver Panel

11.4.2.4. Lipid Profile

11.4.2.5. Renal Profile

11.4.2.6. Thyroid Function Panel

11.4.2.7. Specialty Chemical Tests

11.4.2.8. Molecular Diagnostics

11.4.2.9. Polymerase Chain Reaction

11.4.2.10. Isothermal Nucleic Acid Amplification Technology

11.4.2.11. Microarray

11.4.2.12. Hybridization

11.4.2.13. DNA Sequencing & Next-Generation Sequencing

11.4.2.14. Other Mdx Technologies

11.4.3. Microbiology

11.4.4. Hematology

11.4.5. Coagulation and Haemostasis

11.4.6. Urinalysis

11.4.7. Other IVD Technologies

11.5. Asia Pacific In Vitro Diagnostic Market, By Application

11.5.1. Infectious Diseases

11.5.2. Diabetes

11.5.3. Oncology

11.5.4. Cardiology

11.5.5. Autoimmune Diseases

11.5.6. Nephrology

11.5.7. Drug Testing/Pharmacogenomics

11.5.8. HIV/Aids

11.5.9. Other Applications

11.6. Asia Pacific In Vitro Diagnostic Market, By End User

11.6.1. Hospitals

11.6.2. Laboratories

11.6.2.1. Large/Reference Laboratories

11.6.2.2. Medium-Sized Laboratories

11.6.2.3. Small Laboratories

11.6.3. Point-Of-Care Testing

11.6.4. Patient Self-Testing

11.6.5. Academic Institutes

11.6.6. Other End Users

11.7. Asia Pacific In Vitro Diagnostic Market Attractiveness Index

11.7.1. By Country

11.7.2. By Product & Services

11.7.3. By Technology

11.7.4. By Application

11.7.5. By End User

12. Middle East In Vitro Diagnostic Market Analysis and Forecast, 2019–2027

12.1. Introduction

12.1.1. Annual Growth Rate Comparison, By Country

12.1.2. BPS Analysis, By Country

12.2. Market (US$Mn) Forecast, By Country

12.2.1. GCC Countries In Vitro Diagnostic Market

12.2.2. Israel In Vitro Diagnostic Market

12.2.3. Oman In Vitro Diagnostic Market

12.2.4. Rest of Middle East In Vitro Diagnostic Market

12.3. Middle East In Vitro Diagnostic Market, By Product & Services

12.3.1. Reagents & Kits

12.3.2. Instruments

12.3.2.1. Fully Automated Instruments

12.3.2.2. Semi-Automated Instruments

12.3.2.3. Other Instruments

12.3.3. Data Management Software

12.3.4. Services

12.4. Middle East In Vitro Diagnostic Market, By Technology

12.4.1. Immunoassay/Immunochemistry

12.4.1.1. Enzyme-Linked Immunosorbent Assay

12.4.1.1.1. Chemiluminescence Immunoassays

12.4.1.1.2. Fluorescence Immunoassays

12.4.1.1.3. Colorimetric Immunoassays

12.4.1.2. Radioimmunoassay

12.4.1.3. Rapid Test

12.4.1.4. Western Blotting

12.4.1.5. Enzyme-Linked Immunospot Assays

12.4.2. Clinical Chemistry

12.4.2.1. Basic Metabolic Panel

12.4.2.2. Electrolyte Panel

12.4.2.3. Liver Panel

12.4.2.4. Lipid Profile

12.4.2.5. Renal Profile

12.4.2.6. Thyroid Function Panel

12.4.2.7. Specialty Chemical Tests

12.4.2.8. Molecular Diagnostics

12.4.2.9. Polymerase Chain Reaction

12.4.2.10. Isothermal Nucleic Acid Amplification Technology

12.4.2.11. Microarray

12.4.2.12. Hybridization

12.4.2.13. DNA Sequencing & Next-Generation Sequencing

12.4.2.14. Other Mdx Technologies

12.4.3. Microbiology

12.4.4. Hematology

12.4.5. Coagulation and Haemostasis

12.4.6. Urinalysis

12.4.7. Other IVD Technologies

12.5. Middle East In Vitro Diagnostic Market, By Application

12.5.1. Infectious Diseases

12.5.2. Diabetes

12.5.3. Oncology

12.5.4. Cardiology

12.5.5. Autoimmune Diseases

12.5.6. Nephrology

12.5.7. Drug Testing/Pharmacogenomics

12.5.8. HIV/Aids

12.5.9. Other Applications

12.6. Middle East In Vitro Diagnostic Market, By End User

12.6.1. Hospitals

12.6.2. Laboratories

12.6.2.1. Large/Reference Laboratories

12.6.2.2. Medium-Sized Laboratories

12.6.2.3. Small Laboratories

12.6.3. Point-Of-Care Testing

12.6.4. Patient Self-Testing

12.6.5. Academic Institutes

12.6.6. Other End Users

12.7. Middle East In Vitro Diagnostic Market Attractiveness Index

12.7.1. By Country

12.7.2. By Product & Services

12.7.3. By Technology

12.7.4. By Application

12.7.5. By End User

13. Africa In Vitro Diagnostic Market Analysis and Forecast, 2019–2027

13.1. Introduction

13.1.1. Annual Growth Rate Comparison, By Country

13.1.2. BPS Analysis, By Country

13.2. Market (US$Mn) Forecast, By Country

13.2.1. South Africa In Vitro Diagnostic Market

13.2.2. Egypt In Vitro Diagnostic Market

13.2.3. North Africa In Vitro Diagnostic Market

13.2.4. Rest of Africa In Vitro Diagnostic Market

13.3. Africa In Vitro Diagnostic Market, By Product & Services

13.3.1. Reagents & Kits

13.3.2. Instruments

13.3.2.1. Fully Automated Instruments

13.3.2.2. Semi-Automated Instruments

13.3.2.3. Other Instruments

13.3.3. Data Management Software

13.3.4. Services

13.4. Africa In Vitro Diagnostic Market, By Technology

13.4.1. Immunoassay/Immunochemistry

13.4.1.1. Enzyme-Linked Immunosorbent Assay

13.4.1.1.1. Chemiluminescence Immunoassays

13.4.1.1.2. Fluorescence Immunoassays

13.4.1.1.3. Colorimetric Immunoassays

13.4.1.2. Radioimmunoassay

13.4.1.3. Rapid Test

13.4.1.4. Western Blotting

13.4.1.5. Enzyme-Linked Immunospot Assays

13.4.2. Clinical Chemistry

13.4.2.1. Basic Metabolic Panel

13.4.2.2. Electrolyte Panel

13.4.2.3. Liver Panel

13.4.2.4. Lipid Profile

13.4.2.5. Renal Profile

13.4.2.6. Thyroid Function Panel

13.4.2.7. Specialty Chemical Tests

13.4.2.8. Molecular Diagnostics

13.4.2.9. Polymerase Chain Reaction

13.4.2.10. Isothermal Nucleic Acid Amplification Technology

13.4.2.11. Microarray

13.4.2.12. Hybridization

13.4.2.13. DNA Sequencing & Next-Generation Sequencing

13.4.2.14. Other Mdx Technologies

13.4.3. Microbiology

13.4.4. Hematology

13.4.5. Coagulation and Haemostasis

13.4.6. Urinalysis

13.4.7. Other IVD Technologies

13.5. Africa In Vitro Diagnostic Market, By Application

13.5.1. Infectious Diseases

13.5.2. Diabetes

13.5.3. Oncology

13.5.4. Cardiology

13.5.5. Autoimmune Diseases

13.5.6. Nephrology

13.5.7. Drug Testing/Pharmacogenomics

13.5.8. HIV/Aids

13.5.9. Other Applications

13.6. Africa In Vitro Diagnostic Market, By End User

13.6.1. Hospitals

13.6.2. Laboratories

13.6.2.1. Large/Reference Laboratories

13.6.2.2. Medium-Sized Laboratories

13.6.2.3. Small Laboratories

13.6.3. Point-Of-Care Testing

13.6.4. Patient Self-Testing

13.6.5. Academic Institutes

13.6.6. Other End Users

13.7. Africa In Vitro Diagnostic Market Attractiveness Index

13.7.1. By Country

13.7.2. By Product & Services

13.7.3. By Technology

13.7.4. By Application

13.7.5. By End User

14. Recommendation

14.1. Market Strategy

15. Competitive Landscape

15.1. Competition Dashboard

15.2. List and Company Overview of Global Key Players

15.3. Company Profiles

15.3.1. Roche Diagnostics

15.3.1.1. Company Overview

15.3.1.2. Financial Overview

15.3.1.3. Product & Services Portfolio

15.3.1.4. Key Developments

15.3.1.5. Business Strategies

15.3.2. Siemens Healthineers

15.3.3. Danaher Corporation

15.3.4. Abbott Laboratories

15.3.5. Thermo Fisher Scientific

15.3.6. Johnson & Johnson

15.3.7. Becton, Dickinson and Company

15.3.8. Bio-Rad Laboratories

15.3.9. Sysmex Corporation

15.3.10. bioMérieux

15.3.11. DiaSorin

15.3.12. Ortho Clinical Diagnostics

15.3.13. Agilent Technologies

15.3.14. QIAGEN

16. Acronyms

Frequently Asked Questions

What is the projected market size & Compound Annual Growth Rate (CAGR) of the market?

The global In Vitro Diagnostics (IVD) market in 2020 is estimated for more than US$ 70,561.9 Mn and expected to reach a value of US$ 1,03,310.9 Mn by 2028 with a significant CAGR of 4.9%.
What are the key factors driving the growth of market?

Technological advancements in testing methods as well as in analyzer instruments and evolving regulations for in-vitro diagnostics are the key factors driving the growth of market
What segments are covered in market report?

The global in vitro diagnostics market is segmented on the basis of product type, technology, end user and region
What are the key participating players in the market?

Abbott Laboratories, Merck KGaG, F. Hoffman-La Roche AG, Becton Dickinson & Company, Danaher Corporation, Thermo Fisher Scientific Inc., Qiagen N.V., Diasorin S.P.A., biomerieux SA, Alere Inc., Bayer AG, Bio-Rad Laboratories Inc., and Sysmex Corporation are the key participating players in the market